| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Copy Number Variations | 17 | 2019 | 949 | 1.900 |
Why?
|
| Genetic Diseases, Inborn | 10 | 2019 | 443 | 1.710 |
Why?
|
| Gene Rearrangement | 10 | 2019 | 320 | 1.230 |
Why?
|
| Gene Duplication | 6 | 2015 | 362 | 0.920 |
Why?
|
| Chromosome Aberrations | 5 | 2019 | 616 | 0.870 |
Why?
|
| DNA Replication | 7 | 2019 | 352 | 0.790 |
Why?
|
| Phenotype | 22 | 2019 | 4255 | 0.760 |
Why?
|
| Sequence Analysis, DNA | 9 | 2019 | 1758 | 0.700 |
Why?
|
| Genomic Instability | 4 | 2017 | 228 | 0.700 |
Why?
|
| Smith-Magenis Syndrome | 7 | 2019 | 105 | 0.680 |
Why?
|
| Chromosomes, Human, Pair 17 | 8 | 2019 | 369 | 0.680 |
Why?
|
| Developmental Disabilities | 7 | 2019 | 712 | 0.660 |
Why?
|
| Chromosome Duplication | 8 | 2019 | 147 | 0.630 |
Why?
|
| Mutation | 12 | 2019 | 5825 | 0.630 |
Why?
|
| Alleles | 12 | 2019 | 1613 | 0.610 |
Why?
|
| Exome | 12 | 2019 | 1034 | 0.610 |
Why?
|
| Charcot-Marie-Tooth Disease | 3 | 2015 | 199 | 0.590 |
Why?
|
| Genome, Human | 8 | 2019 | 1273 | 0.560 |
Why?
|
| Intellectual Disability | 8 | 2019 | 1056 | 0.530 |
Why?
|
| Genetic Testing | 3 | 2019 | 1002 | 0.530 |
Why?
|
| Comparative Genomic Hybridization | 12 | 2015 | 572 | 0.520 |
Why?
|
| Genomic Structural Variation | 3 | 2019 | 86 | 0.500 |
Why?
|
| Gigantism | 4 | 2016 | 14 | 0.500 |
Why?
|
| Homologous Recombination | 3 | 2016 | 91 | 0.490 |
Why?
|
| Chromosomes, Human, X | 3 | 2015 | 157 | 0.480 |
Why?
|
| DNA Repair | 4 | 2019 | 585 | 0.430 |
Why?
|
| T-Box Domain Proteins | 3 | 2019 | 112 | 0.410 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 192 | 0.400 |
Why?
|
| Gene Dosage | 6 | 2019 | 439 | 0.400 |
Why?
|
| Transcription Factors | 9 | 2019 | 2580 | 0.390 |
Why?
|
| Pedigree | 14 | 2019 | 1605 | 0.390 |
Why?
|
| Chromosome Pairing | 1 | 2011 | 7 | 0.380 |
Why?
|
| Crossing Over, Genetic | 1 | 2011 | 50 | 0.380 |
Why?
|
| Scoliosis | 3 | 2019 | 135 | 0.380 |
Why?
|
| Base Sequence | 8 | 2016 | 3090 | 0.360 |
Why?
|
| Mutation, Missense | 4 | 2019 | 875 | 0.350 |
Why?
|
| Inheritance Patterns | 3 | 2019 | 127 | 0.340 |
Why?
|
| Myelin Proteins | 3 | 2016 | 75 | 0.330 |
Why?
|
| Molecular Sequence Data | 7 | 2016 | 3877 | 0.330 |
Why?
|
| Chromosome Breakage | 4 | 2017 | 167 | 0.330 |
Why?
|
| Genetic Diseases, X-Linked | 3 | 2016 | 64 | 0.320 |
Why?
|
| Intracranial Aneurysm | 2 | 2019 | 88 | 0.300 |
Why?
|
| Abnormalities, Multiple | 9 | 2019 | 960 | 0.290 |
Why?
|
| Humans | 63 | 2019 | 124703 | 0.280 |
Why?
|
| Chromosome Disorders | 6 | 2019 | 311 | 0.280 |
Why?
|
| Sequence Deletion | 6 | 2016 | 526 | 0.280 |
Why?
|
| Child, Preschool | 25 | 2019 | 14013 | 0.280 |
Why?
|
| Genetic Variation | 3 | 2019 | 1497 | 0.280 |
Why?
|
| Models, Genetic | 6 | 2019 | 759 | 0.280 |
Why?
|
| Male | 41 | 2019 | 61264 | 0.270 |
Why?
|
| Membrane Proteins | 5 | 2019 | 1532 | 0.270 |
Why?
|
| Recombination, Genetic | 5 | 2019 | 448 | 0.260 |
Why?
|
| Female | 41 | 2019 | 66557 | 0.260 |
Why?
|
| Spine | 4 | 2019 | 142 | 0.250 |
Why?
|
| Bardet-Biedl Syndrome | 2 | 2016 | 38 | 0.240 |
Why?
|
| Acromegaly | 2 | 2015 | 8 | 0.240 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 641 | 0.230 |
Why?
|
| Infant | 18 | 2019 | 12471 | 0.230 |
Why?
|
| Congenital Abnormalities | 2 | 2018 | 254 | 0.230 |
Why?
|
| INDEL Mutation | 3 | 2019 | 87 | 0.230 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2018 | 156 | 0.230 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2005 | 71 | 0.230 |
Why?
|
| Genomics | 5 | 2019 | 1501 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 3154 | 0.220 |
Why?
|
| Gene Deletion | 4 | 2016 | 789 | 0.220 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2018 | 883 | 0.220 |
Why?
|
| Meningioma | 1 | 2005 | 120 | 0.210 |
Why?
|
| Chromosome Breakpoints | 3 | 2019 | 80 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2019 | 2634 | 0.200 |
Why?
|
| Segmental Duplications, Genomic | 3 | 2011 | 81 | 0.190 |
Why?
|
| Haploinsufficiency | 3 | 2019 | 258 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2015 | 150 | 0.190 |
Why?
|
| Child | 24 | 2019 | 24371 | 0.190 |
Why?
|
| Exons | 4 | 2017 | 796 | 0.190 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 539 | 0.190 |
Why?
|
| Genetic Heterogeneity | 2 | 2019 | 126 | 0.190 |
Why?
|
| Muscle Weakness | 2 | 2016 | 84 | 0.180 |
Why?
|
| DNA-Binding Proteins | 3 | 2017 | 2043 | 0.170 |
Why?
|
| Cohort Studies | 8 | 2019 | 4803 | 0.170 |
Why?
|
| Dynamins | 1 | 2019 | 38 | 0.160 |
Why?
|
| Face | 2 | 2017 | 179 | 0.160 |
Why?
|
| Carboxypeptidases | 1 | 2018 | 16 | 0.160 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2019 | 16 | 0.160 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2019 | 37 | 0.160 |
Why?
|
| Megakaryocyte Progenitor Cells | 1 | 2018 | 6 | 0.150 |
Why?
|
| Craniofacial Abnormalities | 2 | 2019 | 240 | 0.150 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2019 | 54 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2005 | 1140 | 0.150 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 25 | 0.150 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2018 | 64 | 0.150 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2018 | 13 | 0.150 |
Why?
|
| Dwarfism | 1 | 2019 | 98 | 0.150 |
Why?
|
| Peripheral Nerves | 1 | 2018 | 85 | 0.150 |
Why?
|
| Homozygote | 5 | 2019 | 548 | 0.150 |
Why?
|
| Microarray Analysis | 1 | 2019 | 229 | 0.150 |
Why?
|
| GABAergic Neurons | 1 | 2019 | 61 | 0.150 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2018 | 30 | 0.150 |
Why?
|
| Nuclear Proteins | 3 | 2019 | 1265 | 0.150 |
Why?
|
| Endocytosis | 1 | 2018 | 125 | 0.150 |
Why?
|
| Microcephaly | 2 | 2019 | 330 | 0.150 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2018 | 65 | 0.150 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2018 | 115 | 0.150 |
Why?
|
| Twins, Monozygotic | 1 | 2018 | 117 | 0.150 |
Why?
|
| Holoprosencephaly | 1 | 2017 | 23 | 0.150 |
Why?
|
| Pituitary Neoplasms | 2 | 2015 | 80 | 0.150 |
Why?
|
| Muscle Hypotonia | 1 | 2019 | 187 | 0.150 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2018 | 93 | 0.140 |
Why?
|
| Motor Neurons | 1 | 2018 | 141 | 0.140 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2019 | 153 | 0.140 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 149 | 0.140 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 126 | 0.140 |
Why?
|
| Fanconi Anemia | 1 | 2017 | 44 | 0.140 |
Why?
|
| CDC2 Protein Kinase | 1 | 2017 | 34 | 0.140 |
Why?
|
| Adenoma | 2 | 2015 | 129 | 0.140 |
Why?
|
| Fetus | 2 | 2018 | 585 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2019 | 266 | 0.140 |
Why?
|
| Hypothalamus | 1 | 2019 | 212 | 0.140 |
Why?
|
| Gametogenesis | 1 | 2017 | 24 | 0.140 |
Why?
|
| Purkinje Cells | 1 | 2018 | 159 | 0.140 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2017 | 20 | 0.140 |
Why?
|
| Cell Cycle | 1 | 2019 | 610 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 210 | 0.140 |
Why?
|
| Neoplasms | 1 | 2011 | 2788 | 0.130 |
Why?
|
| Genetic Carrier Screening | 1 | 2017 | 68 | 0.130 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2017 | 44 | 0.130 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2016 | 12 | 0.130 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2016 | 36 | 0.130 |
Why?
|
| Memory Disorders | 1 | 2019 | 236 | 0.130 |
Why?
|
| Syndrome | 5 | 2018 | 1119 | 0.130 |
Why?
|
| Adolescent | 15 | 2019 | 19278 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2018 | 501 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2019 | 299 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 409 | 0.130 |
Why?
|
| Failure to Thrive | 1 | 2016 | 90 | 0.130 |
Why?
|
| Genetic Loci | 2 | 2014 | 339 | 0.130 |
Why?
|
| Cleft Lip | 1 | 2017 | 125 | 0.130 |
Why?
|
| Cleft Palate | 1 | 2017 | 140 | 0.130 |
Why?
|
| Autoantigens | 1 | 2016 | 118 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 778 | 0.130 |
Why?
|
| Computational Biology | 2 | 2019 | 811 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 118 | 0.120 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 36 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 457 | 0.120 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2015 | 39 | 0.120 |
Why?
|
| Adult | 17 | 2019 | 29481 | 0.120 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 282 | 0.120 |
Why?
|
| Memory | 1 | 2019 | 361 | 0.120 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2016 | 56 | 0.120 |
Why?
|
| DNA End-Joining Repair | 2 | 2012 | 34 | 0.120 |
Why?
|
| Hematologic Neoplasms | 1 | 2018 | 284 | 0.120 |
Why?
|
| Embryonic Development | 1 | 2017 | 214 | 0.120 |
Why?
|
| Trans-Activators | 3 | 2016 | 799 | 0.120 |
Why?
|
| Cerebellum | 1 | 2018 | 413 | 0.120 |
Why?
|
| Adenosine Triphosphatases | 2 | 2017 | 200 | 0.120 |
Why?
|
| Loss of Heterozygosity | 1 | 2015 | 125 | 0.120 |
Why?
|
| Uniparental Disomy | 1 | 2015 | 49 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2019 | 815 | 0.110 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 57 | 0.110 |
Why?
|
| Gene Order | 2 | 2011 | 79 | 0.110 |
Why?
|
| Clone Cells | 1 | 2014 | 166 | 0.110 |
Why?
|
| Mosaicism | 1 | 2016 | 240 | 0.110 |
Why?
|
| Seizures | 1 | 2019 | 874 | 0.110 |
Why?
|
| Polyneuropathies | 1 | 2014 | 29 | 0.110 |
Why?
|
| Aneuploidy | 1 | 2014 | 152 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 762 | 0.110 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 479 | 0.110 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 543 | 0.110 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 119 | 0.110 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2014 | 395 | 0.110 |
Why?
|
| Bone Marrow | 2 | 2018 | 324 | 0.100 |
Why?
|
| Muscular Atrophy | 1 | 2014 | 75 | 0.100 |
Why?
|
| Microsatellite Repeats | 1 | 2014 | 221 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 376 | 0.100 |
Why?
|
| Young Adult | 9 | 2019 | 9022 | 0.100 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2018 | 968 | 0.100 |
Why?
|
| Sex Chromosomes | 1 | 2012 | 34 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 669 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 292 | 0.100 |
Why?
|
| Haplotypes | 3 | 2019 | 522 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 459 | 0.100 |
Why?
|
| Osteochondrodysplasias | 1 | 2012 | 66 | 0.100 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 130 | 0.090 |
Why?
|
| Family | 3 | 2019 | 563 | 0.090 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2011 | 53 | 0.090 |
Why?
|
| Oligonucleotides | 1 | 2011 | 89 | 0.090 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2011 | 29 | 0.090 |
Why?
|
| Alu Elements | 1 | 2011 | 65 | 0.090 |
Why?
|
| Heterozygote | 3 | 2019 | 671 | 0.090 |
Why?
|
| Infant, Newborn | 6 | 2019 | 8187 | 0.090 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2012 | 294 | 0.090 |
Why?
|
| Animals | 9 | 2019 | 34028 | 0.090 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2011 | 369 | 0.090 |
Why?
|
| Growth Disorders | 1 | 2012 | 209 | 0.090 |
Why?
|
| Paralysis | 1 | 2010 | 35 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 3 | 2016 | 267 | 0.080 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2011 | 309 | 0.080 |
Why?
|
| Zebrafish | 3 | 2018 | 384 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2011 | 621 | 0.080 |
Why?
|
| Heart Defects, Congenital | 2 | 2018 | 1815 | 0.080 |
Why?
|
| Mice | 5 | 2019 | 17580 | 0.080 |
Why?
|
| Chromosome Mapping | 1 | 2011 | 1079 | 0.070 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 357 | 0.070 |
Why?
|
| Genotype | 3 | 2019 | 2556 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2285 | 0.070 |
Why?
|
| DNA | 1 | 2012 | 1597 | 0.070 |
Why?
|
| Gastrulation | 2 | 2016 | 16 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2019 | 830 | 0.060 |
Why?
|
| Subarachnoid Space | 1 | 2005 | 24 | 0.060 |
Why?
|
| Dura Mater | 1 | 2005 | 25 | 0.060 |
Why?
|
| Radiography | 2 | 2019 | 821 | 0.060 |
Why?
|
| Spinal Cord Compression | 1 | 2005 | 30 | 0.060 |
Why?
|
| Arthralgia | 1 | 2005 | 54 | 0.060 |
Why?
|
| Lumbar Vertebrae | 1 | 2005 | 113 | 0.060 |
Why?
|
| Gene Frequency | 2 | 2018 | 722 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 1697 | 0.050 |
Why?
|
| Neurosurgical Procedures | 1 | 2005 | 304 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 1586 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 5160 | 0.050 |
Why?
|
| Facies | 2 | 2013 | 153 | 0.050 |
Why?
|
| Gene Expression | 2 | 2019 | 1560 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2018 | 16325 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 63 | 0.040 |
Why?
|
| Peroxisomes | 1 | 2019 | 36 | 0.040 |
Why?
|
| Serine-Type D-Ala-D-Ala Carboxypeptidase | 1 | 2018 | 4 | 0.040 |
Why?
|
| Transferrin | 1 | 2018 | 49 | 0.040 |
Why?
|
| Receptors, GABA-A | 1 | 2019 | 59 | 0.040 |
Why?
|
| Collagen Type III | 1 | 2018 | 21 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 289 | 0.040 |
Why?
|
| Molecular Motor Proteins | 1 | 2018 | 29 | 0.040 |
Why?
|
| Endosomes | 1 | 2018 | 65 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 133 | 0.040 |
Why?
|
| Fibrillin-1 | 1 | 2018 | 58 | 0.040 |
Why?
|
| De Lange Syndrome | 1 | 2018 | 44 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 380 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2018 | 77 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 143 | 0.040 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2019 | 130 | 0.040 |
Why?
|
| Age Factors | 1 | 2005 | 2819 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 60 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 574 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2019 | 658 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4345 | 0.040 |
Why?
|
| Myelin Sheath | 1 | 2018 | 121 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 177 | 0.040 |
Why?
|
| Infant Care | 1 | 2017 | 46 | 0.040 |
Why?
|
| China | 1 | 2018 | 243 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 1016 | 0.040 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2018 | 71 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 274 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 314 | 0.030 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2017 | 31 | 0.030 |
Why?
|
| Survival of Motor Neuron 2 Protein | 1 | 2017 | 13 | 0.030 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2017 | 67 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2019 | 266 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 1486 | 0.030 |
Why?
|
| Middle Aged | 5 | 2019 | 26796 | 0.030 |
Why?
|
| Histone Deacetylase 1 | 1 | 2016 | 21 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 101 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 357 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 103 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 310 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 272 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2019 | 473 | 0.030 |
Why?
|
| Megalencephaly | 1 | 2016 | 57 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2017 | 220 | 0.030 |
Why?
|
| Micrognathism | 1 | 2016 | 65 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2019 | 1068 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 29 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 377 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 281 | 0.030 |
Why?
|
| Hand Deformities, Congenital | 1 | 2016 | 88 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2016 | 93 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2016 | 185 | 0.030 |
Why?
|
| Brain | 2 | 2018 | 2982 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 227 | 0.030 |
Why?
|
| Primates | 1 | 2015 | 77 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2016 | 113 | 0.030 |
Why?
|
| Amino Acids | 1 | 2018 | 664 | 0.030 |
Why?
|
| Neck | 1 | 2016 | 135 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 38 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2015 | 12354 | 0.030 |
Why?
|
| Peptides | 1 | 2018 | 795 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 120 | 0.030 |
Why?
|
| Hearing Loss | 1 | 2016 | 134 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 544 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2016 | 231 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2016 | 189 | 0.030 |
Why?
|
| Biopsy | 1 | 2018 | 1237 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2704 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 555 | 0.030 |
Why?
|
| Human Growth Hormone | 1 | 2014 | 74 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2746 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 882 | 0.030 |
Why?
|
| Mitochondria | 1 | 2019 | 681 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 669 | 0.030 |
Why?
|
| Lymphocytes | 2 | 1989 | 406 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1177 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 524 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2016 | 676 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2014 | 126 | 0.030 |
Why?
|
| Bile Acids and Salts | 1 | 2016 | 242 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 3556 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 2383 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2018 | 1022 | 0.030 |
Why?
|
| Age of Onset | 1 | 2014 | 591 | 0.030 |
Why?
|
| Short Stature Homeobox Protein | 1 | 2012 | 11 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1391 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2012 | 131 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 656 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 1311 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 3038 | 0.020 |
Why?
|
| Extremities | 1 | 2012 | 82 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2050 | 0.020 |
Why?
|
| Spastin | 1 | 2011 | 8 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 1684 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2014 | 541 | 0.020 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 93 | 0.020 |
Why?
|
| Introns | 1 | 2011 | 299 | 0.020 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2010 | 36 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2877 | 0.020 |
Why?
|
| United States | 2 | 2019 | 10897 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 2010 | 67 | 0.020 |
Why?
|
| Inverted Repeat Sequences | 1 | 2009 | 13 | 0.020 |
Why?
|
| Japan | 1 | 1989 | 133 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2009 | 97 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2009 | 26 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 3584 | 0.020 |
Why?
|
| Necrosis | 1 | 1989 | 208 | 0.020 |
Why?
|
| Language Development Disorders | 1 | 2009 | 174 | 0.020 |
Why?
|
| Fibrosis | 1 | 1989 | 431 | 0.020 |
Why?
|
| Kidney | 1 | 2014 | 1358 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 224 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2009 | 647 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2009 | 342 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 4626 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 4493 | 0.020 |
Why?
|
| Sex Factors | 1 | 1989 | 1286 | 0.020 |
Why?
|
| Hemoglobin, Sickle | 1 | 1984 | 20 | 0.010 |
Why?
|
| Fetal Hemoglobin | 1 | 1984 | 28 | 0.010 |
Why?
|
| Hemoglobins, Abnormal | 1 | 1984 | 13 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2011 | 798 | 0.010 |
Why?
|
| Aging | 1 | 1989 | 1182 | 0.010 |
Why?
|
| Epilepsy | 1 | 2009 | 871 | 0.010 |
Why?
|
| Isoelectric Focusing | 1 | 1981 | 24 | 0.010 |
Why?
|
| Granulocytes | 1 | 1981 | 65 | 0.010 |
Why?
|
| Cell Separation | 1 | 1981 | 226 | 0.010 |
Why?
|
| Aged | 1 | 1989 | 19763 | 0.010 |
Why?
|
| Blood Protein Electrophoresis | 1 | 1984 | 5 | 0.000 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1984 | 18 | 0.000 |
Why?
|
| Alabama | 1 | 1984 | 46 | 0.000 |
Why?
|